These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 6110167)

  • 1. Thermodynamics of agonist and antagonist interactions with mammalian beta-adrenergic receptors.
    Weiland GA; Minneman KP; Molinoff PB
    Mol Pharmacol; 1980 Nov; 18(3):341-7. PubMed ID: 6110167
    [No Abstract]   [Full Text] [Related]  

  • 2. The pharmacological specificity of beta-1 and beta-2 adrenergic receptors in rat heart and lung in vitro.
    Minneman KP; Hegstrand LR; Molinoff PB
    Mol Pharmacol; 1979 Jul; 16(1):21-33. PubMed ID: 39243
    [No Abstract]   [Full Text] [Related]  

  • 3. Interactions of agonists and antagonists with beta-adrenergic receptors.
    Molinoff PB; Weiland GA; Heidenreich KA; Pittman RN; Minneman KP
    Adv Cyclic Nucleotide Res; 1981; 14():51-67. PubMed ID: 6116391
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Simultaneous determination of beta-1 and beta-2-adrenergic receptors in tissues containing both receptor subtypes.
    Minneman KP; Hegstrand LR; Molinoff PB
    Mol Pharmacol; 1979 Jul; 16(1):34-46. PubMed ID: 39246
    [No Abstract]   [Full Text] [Related]  

  • 5. Agonist- induced transconformation of beta-adrenergic receptors, and adenylate cyclase activation [proceedings].
    Vauquelin G; Bottari S; Strosberg AD
    Arch Int Physiol Biochim; 1979 Oct; 87(4):859-60. PubMed ID: 93949
    [No Abstract]   [Full Text] [Related]  

  • 6. Homogeneity of beta 2-adrenoceptors on rat erythrocytes and reticulocytes. A comparison with heterogeneous rat lung beta-adrenoceptors.
    Dickinson K; Richardson A; Nahorski SR
    Mol Pharmacol; 1981 Mar; 19(2):194-204. PubMed ID: 6112660
    [No Abstract]   [Full Text] [Related]  

  • 7. Antagonist dissociation constants and relative agonist efficacies for compounds interacting with beta-1 and beta-2 adrenergic receptors in the rat jugular vein.
    Cohen ML; Ruffolo RR; Wiley KS
    J Pharmacol Exp Ther; 1980 Nov; 215(2):325-31. PubMed ID: 6108357
    [No Abstract]   [Full Text] [Related]  

  • 8. In vitro interactions of agonists and antagonists with beta-adrenergic receptors.
    Abramson SN; Molinoff PB
    Biochem Pharmacol; 1984 Mar; 33(6):869-75. PubMed ID: 6143559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Beta1- and beta2-adrenergic receptors responsible for cyclic AMP accumulation in isolated heart and lung cells.
    Hazeki O; Ui M
    Mol Pharmacol; 1980 Jan; 17(1):8-13. PubMed ID: 6104287
    [No Abstract]   [Full Text] [Related]  

  • 10. An agonist-specific effect of guanine nucleotides on binding to the beta adrenergic receptor.
    Maguire ME; Van Arsdale PM; Gilman AG
    Mol Pharmacol; 1976 Mar; 12(2):335-9. PubMed ID: 4726
    [No Abstract]   [Full Text] [Related]  

  • 11. [Beta-adrenergic receptors in the brain, molecular mechanisms and regulation].
    Staneva-Stoĭcheva D; Bogoslovova T; Popov P
    Eksp Med Morfol; 1986; 25(3):1-6. PubMed ID: 2875865
    [No Abstract]   [Full Text] [Related]  

  • 12. The human heart beta-adrenergic receptors. I. Heterogeneity of the binding sites: presence of 50% beta 1- and 50% beta 2-adrenergic receptors.
    Robberecht P; Delhaye M; Taton G; De Neef P; Waelbroeck M; De Smet JM; Leclerc JL; Chatelain P; Christophe J
    Mol Pharmacol; 1983 Sep; 24(2):169-73. PubMed ID: 6136900
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Axonal transport of beta-adrenergic receptors. Antero- and retrogradely transported receptors differ in agonist affinity and nucleotide sensitivity.
    Zarbin MA; Palacios JM; Wamsley JK; Kuhar MJ
    Mol Pharmacol; 1983 Sep; 24(2):341-8. PubMed ID: 6193407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative analysis of drug-receptor interactions: I. Determination of kinetic and equilibrium properties.
    Weiland GA; Molinoff PB
    Life Sci; 1981 Jul; 29(4):313-30. PubMed ID: 6116136
    [No Abstract]   [Full Text] [Related]  

  • 15. Interactions of full and partial agonists with beta-adrenergic receptors on intact L6 muscle cells.
    Pittman RN; Molinoff PB
    Mol Pharmacol; 1983 Nov; 24(3):398-408. PubMed ID: 6138704
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Presence of both beta1- and beta2-adrenergic receptors in a single cell type.
    Homburger V; Lucas M; Rosenbaum E; Vassent G; Bockaert J
    Mol Pharmacol; 1981 Nov; 20(3):463-9. PubMed ID: 6120448
    [No Abstract]   [Full Text] [Related]  

  • 17. Distribution of beta-adrenergic receptors on human lymphocyte subpopulations.
    Pochet R; Delespesse G; Gausset PW; Collet H
    Clin Exp Immunol; 1979 Dec; 38(3):578-84. PubMed ID: 43789
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Desensitization of adenylate cyclase and down regulation of beta adrenergic receptors after in vivo administration of beta agonist.
    Scarpace PJ; Abrass IB
    J Pharmacol Exp Ther; 1982 Nov; 223(2):327-31. PubMed ID: 6127402
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intact cell binding properties of cells expressing altered beta-adrenergic receptors.
    Zhu SJ; Toews ML
    Mol Pharmacol; 1994 Feb; 45(2):255-61. PubMed ID: 7906855
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantitative resolution of beta-adrenergic receptor subtypes by selective ligand binding: application of a computerized model fitting technique.
    Hancock AA; DeLean AL; Lefkowitz RJ
    Mol Pharmacol; 1979 Jul; 16(1):1-9. PubMed ID: 39239
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 15.